title: Baxter's healthy return. Morgan Stanley's Glenn Reicin says the medical products company's prognosis is finally positive.
authors.forename: David
authors.initials: D
authors.lastname: Stires
mesh_terms: D003132:Commerce / Q000191:economics*; D004864:Equipment and Supplies / Q000191:economics / Q000600:supply & distribution*; D007449:Investments; D014481:United States